[1]
2019. Appropriate Use Criteria for the Integration of Diagnostic and Prognostic Gene Expression Profile Assays into the Management of Cutaneous Malignant Melanoma: An Expert Panel Consensus-Based Modified Delphi Process Assessment. SKIN The Journal of Cutaneous Medicine. 3, 5 (Sep. 2019), 291–306. DOI:https://doi.org/10.25251/skin.3.5.1.